The possibility that another form of cell death, known as necroptosis, was involved in the effects of RSL3 against MM cells was investigated using the receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor necrostatin-1s (Nec-1s). The gene discussed is RIPK1; the disease is Miyoshi myopathy.